Page last updated: 2024-08-23

pravastatin and Atheroma

pravastatin has been researched along with Atheroma in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's20 (83.33)24.3611
2020's4 (16.67)2.80

Authors

AuthorsStudies
Adams, LC; Botnar, RM; Brangsch, J; Hamm, B; Kaufmann, JO; Makowski, MR; Onthank, DC; Reimann, C; Robinson, SP; Thöne-Reineke, C1
Abd Allah, EF; Charan, J; Hashem, A; Jaipal, N; Kashyap, P; Kumar, S; Ram, H; Siddaiah, CN; Singh, BP; Tabassum, B; Tripathi, R1
Chen, Y; Hu, L; Jia, J; Liu, X; Luo, X; Ou, Y; Shen, W; Shi, H; Sun, S; Zhang, H; Zhou, G1
Andia, ME; Botnar, RM; Lavin Plaza, B; Lorrio, S; Phinikaridou, A; Potter, M; Rashid, I1
Abeydeera, D; Demer, LL; Fong, F; Iriana, S; Lu, M; Patel, NR; Qiao, R; Tintut, Y; Xian, JZ1
Heo, TH; Park, KY2
Li, Q; Xiao, S; Zhang, X1
Gao, JH; Lu, JL; Wang, HM1
Liu, G; Liu, M; Wang, M1
Lee, CW; Park, SJ1
Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Morino, Y; Nozue, T; Onishi, Y; Sozu, T; Takeyama, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T1
Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Miyake, S; Morino, Y; Muramatsu, T; Nozato, T; Nozue, T; Onishi, Y; Sato, A; Takeyama, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T2
Heo, TH; Jun, HS; Kwak, MK; Oh, E; Park, KY1
Choi, D; Hong, MK; Jang, Y; Kim, BK; Ko, YG; Lee, JH; Shin, DH1
Castellani, LW; Fogelman, AM; Iikuni, N; La Cava, A; Li, H; Lin, Z; Lusis, AJ; Navab, M; Rullo, OJ; Trejo-Lopez, Y; Tsao, BP; Van Dyck, C; Wang, X; Woo, JM; Woo, KM; Wu, H1
Major, A; Mendez-Fernandez, Y1
Ishibashi, T1
Abela, GS; Durga, S; Huang, R; Janoudi, A; Tamhane, U; Vedre, A1
Hirayama, A; Nagao, K; Tani, S1
Hibi, K; Kunishima, T; Michishita, I; Miyake, S; Morino, Y; Muramatsu, T; Nozue, T; Sato, A; Sozu, T; Takeyama, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T1
Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Nozue, T; Onishi, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S1
Huang, C; Huang, Z; Jiang, H; Wu, G; Xie, Q; Xu, L1

Reviews

1 review(s) available for pravastatin and Atheroma

ArticleYear
[Anti-atherosclerotic and anti-inflammatory effects of statin on cardiovascular disease and their mechanisms].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1

    Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mevalonic Acid; Monomeric GTP-Binding Proteins; Plaque, Atherosclerotic; Pravastatin; Primary Prevention; Randomized Controlled Trials as Topic; Secondary Prevention

2011

Trials

7 trial(s) available for pravastatin and Atheroma

ArticleYear
Comparison and analysis of the therapeutic effect of different statins in the treatment of atherosclerosis.
    Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:4(Special)

    Topics: Adult; Aged; Atherosclerosis; Atorvastatin; Carotid Arteries; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Plaque, Atherosclerotic; Pravastatin; Simvastatin

2018
C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
    Journal of atherosclerosis and thrombosis, 2013, Volume: 20, Issue:9

    Topics: Aged; Angina Pectoris; C-Reactive Protein; Cardiovascular Diseases; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Japan; Male; Middle Aged; Myocardial Infarction; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Quinolines; Regression Analysis; Risk Factors; Treatment Outcome; Ultrasonography, Interventional

2013
Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound.
    Heart and vessels, 2015, Volume: 30, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Necrosis; Phenotype; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Quinolines; Ultrasonography, Interventional

2015
Early Effects of Intensive Lipid-Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound.
    Yonsei medical journal, 2016, Volume: 57, Issue:5

    Topics: Aged; Cholesterol, LDL; Coronary Artery Disease; Drug Administration Schedule; Ezetimibe, Simvastatin Drug Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2016
Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.
    American heart journal, 2012, Volume: 163, Issue:2

    Topics: Aged; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Quinolines; Treatment Outcome; Ultrasonography, Interventional

2012
Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
    Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:7

    Topics: Aged; Biomarkers; Coronary Artery Disease; Coronary Vessels; Dyslipidemias; Female; Fibrosis; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Kidney; Kidney Diseases; Lipids; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Quinolines; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2012
Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] s
    The American journal of cardiology, 2013, Apr-01, Volume: 111, Issue:7

    Topics: Aged; Angina, Stable; Angina, Unstable; Biomarkers; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Lipids; Male; Plaque, Atherosclerotic; Pravastatin; Quinolines; Regression Analysis; Treatment Outcome; Ultrasonography, Interventional

2013

Other Studies

16 other study(ies) available for pravastatin and Atheroma

ArticleYear
Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Scientific reports, 2019, 09-25, Volume: 9, Issue:1

    Topics: Animals; Contrast Media; Diet, High-Fat; Disease Models, Animal; Elastin; Feasibility Studies; Ferrosoferric Oxide; Gadolinium; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout, ApoE; Nitric Oxide; Plaque, Atherosclerotic; Pravastatin; Sensitivity and Specificity

2019
Phytoconstituents of an ethanolic pod extract of Prosopis cineraria triggers the inhibition of HMG-CoA reductase and the regression of atherosclerotic plaque in hypercholesterolemic rabbits.
    Lipids in health and disease, 2020, Jan-13, Volume: 19, Issue:1

    Topics: Animals; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Disease Models, Animal; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Plant Extracts; Plaque, Atherosclerotic; Pravastatin; Prosopis; Rabbits; Triglycerides

2020
Pravastatin attenuates atherosclerosis after myocardial infarction by inhibiting inflammatory Ly6C
    The Journal of international medical research, 2020, Volume: 48, Issue:7

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Plaque, Atherosclerotic; Pravastatin

2020
Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries.
    Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Aortitis; Atherosclerosis; Brachiocephalic Trunk; Collagen; Disease Models, Animal; Disease Progression; Inflammation Mediators; Interleukin-6; Lipid Metabolism; Male; Mice, Knockout, ApoE; Minocycline; Necrosis; Plaque, Atherosclerotic; Pravastatin; Time Factors

2020
Statin Effects on Vascular Calcification: Microarchitectural Changes in Aortic Calcium Deposits in Aged Hyperlipidemic Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:4

    Topics: Age Factors; Animals; Aorta; Aortic Diseases; Atherosclerosis; Calcium; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Pravastatin; Rupture, Spontaneous; Time Factors; Vascular Calcification

2021
Critical role of TNF inhibition in combination therapy for elderly mice with atherosclerosis.
    Cardiovascular therapeutics, 2017, Volume: 35, Issue:6

    Topics: Aging; Animals; Atherosclerosis; Cholesterol, Dietary; Cytokines; Diet, High-Fat; Drug Therapy, Combination; Etanercept; Fibrinolytic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Pravastatin; Receptors, LDL; Succinates; Tumor Necrosis Factor-alpha

2017
Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
    The Journal of international medical research, 2018, Volume: 46, Issue:8

    Topics: Animals; Anticholesteremic Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Pravastatin

2018
Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:15

    Topics: Adaptor Proteins, Signal Transducing; Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Hyperlipidemias; Interleukin-1; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Pravastatin; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha

2018
Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Cardiovascular therapeutics, 2018, Volume: 36, Issue:6

    Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Cell Adhesion Molecules; Cholesterol, Dietary; Cilostazol; Cytokines; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lipids; Male; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Pravastatin; Receptors, LDL

2018
Statins for treating stable angina: can statins improve the plaque morphology and angina?
    Future cardiology, 2013, Volume: 9, Issue:2

    Topics: Angina Pectoris; Angina, Stable; Atorvastatin; Disease Progression; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plaque, Atherosclerotic; Pravastatin; Pyrroles; Ultrasonography, Interventional

2013
Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Animals; Atherosclerosis; Cell Proliferation; Cytokines; Drug Synergism; Gene Expression Regulation; Gene Knockout Techniques; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Lipids; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Pravastatin; Receptors, LDL; Succinates

2016
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:3

    Topics: Animals; Apolipoprotein A-I; Apolipoproteins E; Bone Density; Chemokines; Cytokines; Disease Models, Animal; fas Receptor; Female; Immunoglobulin G; Lipids; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides; Plaque, Atherosclerotic; Pravastatin

2010
Sizing up stability: combination therapy with Apo-AI peptide mimetics and statins in systemic lupus erythematosus-mediated atherosclerosis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:5

    Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Atherosclerosis; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Mice; Peptides; Plaque, Atherosclerotic; Pravastatin

2010
Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization.
    The American journal of cardiology, 2011, Jun-15, Volume: 107, Issue:12

    Topics: Animals; Atorvastatin; Cholesterol; Crystallization; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Microscopy, Electron, Scanning; Plaque, Atherosclerotic; Pravastatin; Pyrroles; Rabbits; Simvastatin

2011
HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011, Dec-01, Volume: 11, Issue:6

    Topics: Aged; Area Under Curve; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Disease Progression; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Male; Middle Aged; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; ROC Curve; Sensitivity and Specificity; Treatment Outcome

2011
Pravastatin inhibits plaque rupture and subsequent thrombus formation in atherosclerotic rabbits with hyperlipidemia.
    Chemical & pharmaceutical bulletin, 2013, Volume: 61, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anticholesteremic Agents; Aorta; Aorta, Abdominal; Atherosclerosis; Cholesterol; Cholesterol, LDL; Diet, High-Fat; Disease Models, Animal; Histamine; Hyperlipidemias; Male; Plaque, Atherosclerotic; Pravastatin; Rabbits; Thrombosis; Thromboxane B2; Triglycerides; Viper Venoms

2013